David Belinskas, Philip Peters, Paula Beauchemin, Dan Keeney, Eileen Barbieri, Sheila Horgan, Sheila Souda, Elaine Shimkoski, Laurette Boudreau, Mary Trainor, Diane Canzano, Pam Calcagni
cured devices in the U.S. might cause vendors to fundamentally improve the security of their devices for everyone with a global impact, because manufacturers want to be able to sell into the U.S., said Mark Dufresne, director of threat research and adversary prevention at security provider Endgame.